Related Experiment Video
Updated: Aug 29, 2025
09:47
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
1.2K
Multi-modality MRI for Alzheimer's disease detection using deep learning
Latifa Houria1, Noureddine Belkhamsa2, Assia Cherfa2
1LASICOM Laboratory, Department of Electronics, Faculty of Technology, University of Blida 1, Blida, Algeria. houria_latifa@univ-blida.dz.
Physical and Engineering Sciences in Medicine
|September 5, 2022
Summary
This study introduces a new multi-modality MRI approach combining diffusion tensor imaging (DTI) and structural MRI (sMRI) to detect Alzheimer's disease (AD) and mild cognitive impairment (MCI) with high accuracy.
Failed At:
2026-06-19T13:48:52.722750+00:00
Related Concept Videos
01:26Alzheimer's Disease: Overview
644
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
644
01:22Alzheimer's Disease: Treatment
249
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
249